- Home
- SRM vs ABVC Comparison
SRM vs ABVC Comparison
Compare SRM & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRM
- ABVC
- Stock Information
- Founded
- SRM 1979
- ABVC 2015
- Country
- SRM United States
- ABVC United States
- Employees
- SRM N/A
- ABVC N/A
- Industry
- SRM
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- SRM
- ABVC Health Care
- Exchange
- SRM Nasdaq
- ABVC Nasdaq
- Market Cap
- SRM 9.0M
- ABVC 9.9M
- IPO Year
- SRM 2023
- ABVC N/A
- Fundamental
- Price
- SRM $0.79
- ABVC $0.70
- Analyst Decision
- SRM
- ABVC
- Analyst Count
- SRM 0
- ABVC 0
- Target Price
- SRM N/A
- ABVC N/A
- AVG Volume (30 Days)
- SRM 17.4M
- ABVC 1.2M
- Earning Date
- SRM 03-31-2025
- ABVC 03-12-2025
- Dividend Yield
- SRM N/A
- ABVC N/A
- EPS Growth
- SRM N/A
- ABVC N/A
- EPS
- SRM N/A
- ABVC N/A
- Revenue
- SRM $4,594,304.00
- ABVC $509,788.00
- Revenue This Year
- SRM N/A
- ABVC N/A
- Revenue Next Year
- SRM N/A
- ABVC N/A
- P/E Ratio
- SRM N/A
- ABVC N/A
- Revenue Growth
- SRM N/A
- ABVC N/A
- 52 Week Low
- SRM $0.30
- ABVC $0.40
- 52 Week High
- SRM $1.85
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- SRM 66.62
- ABVC 75.66
- Support Level
- SRM $0.30
- ABVC $0.40
- Resistance Level
- SRM $0.93
- ABVC $0.88
- Average True Range (ATR)
- SRM 0.08
- ABVC 0.08
- MACD
- SRM 0.07
- ABVC 0.02
- Stochastic Oscillator
- SRM 62.33
- ABVC 62.42
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.